Overview of Dr. Scandura

Dr. Joseph Scandura is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Lewis Katz School of Medicine at Temple University and has been in practice 20 years. Dr. Scandura accepts several types of health insurance, listed below. She is one of 368 doctors at New York-Presbyterian Hospital and one of 117 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. She has more than 60 publications and over 500 citings.

Education & Training

• Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1999 - 2003

• New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1997 - 1999

• Lewis Katz School of Medicine at Temple UniversityClass of 1997

Certifications & Licensure

Awards, Honors, & Recognition

• CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

Clinical Trials

Publications & Presentations

PubMed

• 1 citations

  Splenomegaly (SPML) in polycythemia vera (PV): its clinical significance and its relation to symptoms, post-polycythemic myelofibrosis (PPMF) and survival.

  Richard T Silver, Katie Erdos, Elwood Taylor 3rd, Joseph M Scandura, Ghaith Abu-Zeinah> ;Leukemia. 2023 Mar 1
• 2 citations

  Expression of ENaC subunits in epithelia.

  Gustavo Frindt, Joel R Meyerson, Alexandra Satty, Joseph M Scandura, Lawrence G Palmer> ;The Journal of General Physiology. 2022 Oct 3
• 2 citations

  Hematopoietic fitness of JAK2V617F myeloproliferative neoplasms is linked to clinical outcome.

  Ghaith Abu-Zeinah, Silvana Di Giandomenico, Daniel Choi, Tatiana Cruz, Katie Erdos, Elwood Taylor, Ellen K Ritchie, Richard T Silver, Joseph M Scandura> ;Blood Advances. 2022 Sep 27
• Join now to see all

Abstracts/Posters

• Low-Dose Epo after Tgf_ Blockade Triggers Robust Erythropoiesis and Increased RBC Production.

  Joseph Scandura, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

• Interferon in Polycythemia Vera (PV) Yields Improved Myelofibrosis-Free and Overall Survival

  Joseph Scandura, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

• Recombinant Interferon-_ Reduces Thrombotic Events in Patients with Polycythemia Vera

  Joseph Scandura, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

• Weill Cornell Team Creates Self-Renewing Hematopoietic Stem Cells for TransplantationMay 17th, 2017

• New Method of Creating Blood Vessel Cells to Repair Injured TissuesJanuary 20th, 2017

• Are You a Patient Taking Vidaza or Dacogen?February 8th, 2016

Hospital Affiliations

Insurance Accepted

• Aetna Choice POS II
  Aetna HMO
  BCBS Blue Card PPO
  BCBS California CaliforniaCare HMO
  BCBS California PowerSelect HMO
  BCBS California PPO
  Blue Shield CA Local Access Plus HMO
  Blue Shield California HMO
  Blue Shield California PPO
  CIGNA HMO
  CIGNA Open Access
  CIGNA PPO
  Empire BCBS HMO
  

  Empire BCBS PPO
  GHI PPO
  Great West PPO
  Health Net California Large Group PPO
  Health Net HMO - Employer Group
  HIP of New York - Select PPO
  Humana ChoiceCare Network PPO
  MVP Healthcare PPO
  Oxford Health Freedom
  Oxford Health Liberty
  Pacificare HMO
  United Healthcare - Direct Choice Plus POS
  United Healthcare - Direct Options PPO
  

• Please verify your coverage with the provider's office directly when scheduling an appointment